Skip to main content


Table 3 Treatment protocols and follow-up in 5 included patients

From: Clinicopathological analysis of proliferative glomerulonephritis with monoclonal IgG deposits in 5 renal allografts

Patient 1 2 3 4 5
  Post-KT 1st post-KT biopsy 2nd post-KT biopsy 3rd post-KT biopsy Post-KT Post-KT 1st post-KT biopsy 2nd post-KT biopsy
Scr/proteinuria at biopsy 0.77/2.21    3.05/6.09 1.2/0.66 1.67/5.5   1.33/37.03
Treatment Plasma exchange None None Rituximab Pulse steroid + bortezomib Bortezomib Sofosbuvir + Daclatasvir + pulse steroid Bortezomib + plasma exchange
Treatment-related complication None    None None Varicella infection None None
Follow-up timea 13 months    39 months 7 months 11 months   1 months
Last follow-up Scr(mg/dl)/Proteinuria(g/d) Death due to pulmonary infections    In dialysis In dialysis 1.1/−   1.25/14
  1. a: follow-up time here denotes the time interval between treatment to last outpatient follow-up